- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 89Zr-girentuximab
Total 315 results
-
TakedaCompletedHodgkin Disease | Lymphoma, Large-Cell, AnaplasticChina
-
Massachusetts General HospitalSeagen Inc.TerminatedGVHD | Graft-vs-Host DiseaseUnited States
-
Federal Research Institute of Pediatric Hematology...RecruitingHodgkin's LymphomaRussian Federation
-
Arbeitsgemeinschaft medikamentoese TumortherapieTerminatedALK+ Anaplastic Large Cell LymphomaAustria
-
Seagen Inc.CompletedHodgkin DiseaseUnited States
-
Radboud University Medical CenterPfizer; ImaginAb, Inc.; University Hospital TuebingenNot yet recruitingNSCLCGermany, Netherlands
-
Jason Robert GotlibSeagen Inc.CompletedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
Memorial Sloan Kettering Cancer CenterMethylGene Inc.CompletedHodgkin LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.Withdrawn
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Nabil AdraTerminatedNonseminomatous Germ Cell Tumor | Testis Cancer | Testicular Cancer | Embryonal Carcinoma | Germ Cell TumorsUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
University of CologneRecruitingClassical Hodgkin LymphomaGermany
-
University of BirminghamMillennium Pharmaceuticals, Inc.; Leukaemia Lymphoma ResearchCompleted
-
Radboud University Medical CenterAstraZenecaCompletedHead and Neck CancerNetherlands
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Seagen Inc.Terminated
-
University of Kansas Medical CenterSeagen Inc.Recruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruiting
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Yale UniversityMerck Sharp & Dohme LLCRecruitingT-Cell LymphomaUnited States
-
Lawson Health Research InstituteSeagen Inc.RecruitingDiffuse Cutaneous Systemic SclerosisCanada
-
Washington University School of MedicineCelgene; Seagen Inc.CompletedLymphoma, Large B-Cell, DiffuseUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Melanoma Stage IIIUnited States
-
Brigham and Women's HospitalCompletedPulmonary Arterial Hypertension | Exercise Associated Pulmonary Arterial HypertensionUnited States
-
Fondazione MichelangeloFondazione IRCCS Istituto Nazionale dei Tumori, Milano; Millennium Pharmaceuticals...CompletedGerm Cell CancerItaly
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung CancerUnited States, Canada
-
Millennium Pharmaceuticals, Inc.CompletedHodgkin LymphomaPoland, Spain, Malaysia, Turkey, Germany, Czechia, Thailand
-
Fondazione Italiana Linfomi ONLUSCompletedPrimary Mediastinal Large B Cell LymphomaItaly
-
Instituto de Ciencia y Tecnología de Alimentos...Completed
-
M.D. Anderson Cancer CenterTerminated
-
Eric Bernicker, MDMillennium Pharmaceuticals, Inc.; The Methodist Hospital Research InstituteWithdrawnCD30-positive Lymphoma | CD30-positive Solid TumorUnited States
-
Hospital Regional de Alta Especialidad del BajioUniversidad de GuanajuatoRecruitingHodgkin Lymphoma | Refractory Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultMexico
-
Seagen Inc.Active, not recruitingDiffuse Large B-cell LymphomaUnited States, France, Australia, Czechia, Italy, Spain, Canada, Belgium, Korea, Republic of, United Kingdom, Poland, Denmark, Germany, Netherlands, Switzerland, Taiwan
-
James BrugarolasRecruitingRenal Cell CarcinomaUnited States
-
Radboud University Medical CenterCompletedMetastatic Clear Cell Renal Cell CarcinomaNetherlands
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
Fox Chase Cancer CenterCelgene Corporation; Seagen Inc.Active, not recruitingCutaneous T-cell Lymphoma (CTCL)United States
-
University of ArizonaWithdrawnFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Mediastinal Large B-cell Lymphoma | Grey Zone Lymphoma | High Grade B Cell LymphomaUnited States
-
Seagen Inc.TerminatedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States
-
Seagen Inc.CompletedAnaplastic Large-Cell LymphomaUnited States
-
Bristol-Myers SquibbSeagen Inc.Active, not recruitingHodgkin DiseaseUnited Kingdom, United States, Poland, Spain, Canada, Czechia, France, Germany, Ireland, Italy, Netherlands
-
University Medical Center GroningenAmsterdam UMC, location VUmc; University Medical Center NijmegenActive, not recruitingMetastatic Breast CancerNetherlands
-
Imagine InstituteTakedaCompletedEnteropathy Associated T-cell LymphomaFrance
-
Universitätsmedizin MannheimKlinikum Ludwigshafen; Wuerzburg University Hospital; KKS Netzwerk; Klinikum Minden and other collaboratorsCompletedCutaneous T Cell LymphomaGermany
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
National Jewish HealthNational Institute on Drug Abuse (NIDA)Active, not recruitingHypnotic Dependence Among Those With InsomniaUnited States
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin Disease | Peripheral T Cell LymphomaUnited States, Canada
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States